Cardiology

<p>Dr Thomas Seck from Boehringer Ingelheim Pharmaceuticals discusses the EMPERIAL trials, which aim to expand the use of empagliflozin for heart failure.</p>

Dr Seth Baum, president of the American Society for Preventive Cardiology, welcomes you to our new podcast series and leaves clinicians with a tip for gaining access to heart failure medication.

Low physical activity levels lead to obesity and other comorbidities. On the other end of the spectrum, too much exercise may not be good for the heart either, according to a recent study. The lead author...

Drs Seth Martin and Vasanth Sathiyakumar discuss their novel method of assessing lipid levels.

Thomas Seck, MD, from Boehringer Ingelheim, spoke with us about the results of the landmark EMPA-REG OUTCOME trial and what they mean for the treatment of diabetes and cardiovascular disease.

<p>Dr Kevin Maki, from Midwest Biomedical Research, speaks to us about his latest review about the effect of omega3 supplementation on cardiometabolic health.</p>

<p>Dr Seth Baum, President of the American Society for Preventive Cardiology, discusses his recent paper on PCSK9 inhibitors.</p>

Dr William Boden from the VA New England Healthcare System discusses the key takeaways from his session about coronary stenting at the American Society for Preventive Cardiology's 2018 Congress on CVD...

In this podcast, Dr. Paul S. Jellinger, the chair of the writing committee, explains the new AACE/ACE Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease.

Is distance from the equator associated with elevated blood pressure levels? What role does vitamin D play? Holly Mattix-Kramer, MD, explains.